510(K) CLEARANCES 75 ▼9RECALLS POSTED 26 ▼13CLASS I 2 ▼4PMA DECISIONS 54 ▲7WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K113220Substantially Equivalent

Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation Catheter (Over-the-Wire)

Boston Scientific Corporation, Maple Grove MN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K113220 is the FDA 510(k) clearance record for EMERGE PTCA DILATATION CATHETER (MONORAIL) EMERGE PTCA DILATATION CATHETER (OVER-THE-WIRE), a class II device, cleared for Boston Scientific Corporation on under FDA product code LOX (Catheters, Transluminal Coronary Angioplasty, Percutaneous). FDA's definition for product code LOX reads: "A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end". FDA records list 1,110 510(k) clearances for Boston Scientific Corporation, from to . As of , FDA records show one recall naming K113220.

Clearance record

Decision date
Received
(142 days to decision)
Product code
LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous
Regulation
21 CFR 870.5100
Device class
Class II
Review panel
Cardiovascular
Applicant
Boston Scientific Corporation One Scimed Pl., Maple Grove MN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LOX

Trailing 12 months
6 clearances under product code LOX in the twelve months to October 2026, April 2026 the highest month at 2.
Show the numbers
Monthly 510(k) clearances under FDA product code LOX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20261
February 20260
March 20261
April 20262
May 20260
June 20260
July 20261
August 20261
September 20260
October 20260